USPTO Examiner OUYANG BO - Art Unit 3794

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18824027TISSUE ABLATION CATHETER WITH PASSIVE CONDUCTIVE ELEMENTS TO SHAPE ELECTRIC FIELDSSeptember 2024November 2024Allow200NoNo
18785346SURGICAL INSTRUMENT WITH MONOPOLAR AND ULTRASONIC FUNCTIONALITY, AND SURGICAL SYSTEMJuly 2024January 2026Abandon1730NoNo
18390687TISSUE CUTTING SYSTEMS AND METHODSDecember 2023July 2025Allow1920NoNo
18390672TISSUE CUTTING SYSTEMS AND METHODSDecember 2023September 2025Allow2130YesNo
18486429CATHETER WITH IMPROVED IRRIGATED TIP ELECTRODE HAVING TWO-PIECE CONSTRUCTION, AND METHOD OF MANUFACTURING THEREFOROctober 2023April 2025Allow1810NoNo
18468546APPARATUS AND METHODS FOR REGULATING CRYOGENIC TREATMENTSeptember 2023December 2025Allow2720NoNo
18465084REUSABLE MINIMALLY INVASIVE SURGICAL INSTRUMENTSeptember 2023April 2025Allow1910NoNo
18461431TISSUE MAPPING AND TREATMENTSeptember 2023January 2024Allow510NoNo
18460488HANDPIECE FOR ELECTRICAL TREATMENT APPLICATORSeptember 2023June 2025Allow2110NoNo
18346575TISSUE ABLATION CATHETER WITH AN INSULATOR BETWEEN INNER AND OUTER ELECTRODESJuly 2023March 2025Allow2100NoNo
18211888DRIVE MECHANISMS FOR SURGICAL INSTRUMENTS SUCH AS FOR USE IN ROBOTIC SURGICAL SYSTEMSJune 2023January 2025Allow1910NoNo
18308279MAXILLARY SINUS PUNCTURE APPARATUSApril 2023April 2025Abandon2410NoNo
18298414SYSTEMS AND METHODS FOR ASSESSING EFFICACY OF RENAL NEUROMODULATION THERAPYApril 2023March 2025Allow2320NoNo
18016948END EFFECTOR ASSEMBLY WITH THIN SEAL PLATESJanuary 2023December 2025Abandon3510NoNo
18083616METHODS AND DEVICES FOR PERFORMING ELECTROSURGERYDecember 2022January 2025Allow2510NoNo
18078795TISSUE ABLATION CATHETER WITH AN INSULATOR BETWEEN INNER AND OUTER ELECTRODESDecember 2022May 2023Allow510YesNo
18073704SURGICAL DEVICE CONNECTION HUBDecember 2022February 2026Abandon3810NoNo
17964561ARTHROSCOPIC DEVICES AND METHODSOctober 2022June 2025Allow3200NoNo
17942914METHODS AND SYSTEMS FOR TREATING DIABETES AND RELATED DISEASES AND DISORDERSSeptember 2022March 2026Abandon4210NoNo
17941864SYSTEMS AND METHODS TO BLOCK OR INHIBIT GAS PROGRESSION DURING SPRAY CRYOTHERAPYSeptember 2022July 2025Abandon3420NoNo
17875193VIRTUAL REALITY WRIST ASSEMBLYJuly 2022March 2025Allow3210NoNo
17863628ULTRAPOLAR ELECTROSURGERY BLADE AND PENCIL FOR USE IN ESU MONOPOLAR AND BIPOLAR MODESJuly 2022November 2024Allow2810NoNo
17861082APPARATUSES AND METHODS FOR DISTINGUISHING CLOT MATERIAL FROM VESSEL WALLJuly 2022December 2024Allow3040YesYes
17850333SURGICAL INSTRUMENTS, RELATED SYSTEMS, AND RELATED METHODSJune 2022February 2025Allow3210YesNo
17841424SYSTEMS AND METHODS FOR INTERRUPTING NERVE ACTIVITY TO TREAT A MEDICAL CONDITIONJune 2022January 2023Allow710YesNo
17834397METHODS FOR ESTIMATING AND CONTROLLING STATE OF ULTRASONIC END EFFECTORJune 2022January 2025Allow3110NoNo
17828394METHOD AND DEVICE FOR INTRAMYOCARDIAL INFUSION OF CONDUCTIVE NANOPARTICLESMay 2022December 2025Abandon4201NoNo
17781238PULSE GENERATING CIRCUIT, AND ELECTROSURGICAL GENERATOR INCORPORATING THE SAMEMay 2022October 2025Abandon4110NoNo
17734496ULTRASONIC ENERGY DEVICE WHICH VARIES PRESSURE APPLIED BY CLAMP ARM TO PROVIDE THRESHOLD CONTROL PRESSURE AT A CUT PROGRESSION LOCATIONMay 2022December 2025Allow4330YesNo
17803294Method and Apparatus for treatment of viral infectionsApril 2022June 2024Allow2620NoNo
17707400STAPLING ASSEMBLY COMPRISING A FIRING MEMBER PUSH TUBEMarch 2022July 2023Allow1630YesNo
17698122MEDICAL INSTRUMENT AND METHOD AND MODULAR SYSTEM FOR MANUFACTURING OF SUCH INSTRUMENTSMarch 2022February 2026Abandon4750NoNo
17690949ROTATABLE SNARES AND RELATED METHODSMarch 2022April 2024Allow2510NoNo
17671044ELECTROSURGICAL DEVICEFebruary 2022March 2026Allow4930NoNo
17592648BIPOLAR ELECTROSURGICAL INSTRUMENT WITH MOVABLE ELECTRODE AND RELATED SYSTEMS AND METHODSFebruary 2022March 2025Allow3730NoNo
17590790UNIVERSAL HANDPIECE FOR ELECTRICAL TREATMENT APPLICATORFebruary 2022June 2023Allow1630YesNo
17572706ELECTRICALLY INSULATIVE ELECTRODE SPACERS, AND RELATED DEVICES, SYSTEMS, AND METHODSJanuary 2022November 2024Allow3410NoNo
17557730SPHINCTEROTOME DEVICE AND METHODS AND USES THEREOFDecember 2021August 2024Abandon3210NoNo
17548316DEVICE AND METHOD FOR FRACTIONAL RF TREATMENT OF THE SKINDecember 2021February 2026Allow5050NoNo
17516503METHODS AND SYSTEMS FOR TREATING DIABETES AND RELATED DISEASES AND DISORDERSNovember 2021February 2026Abandon5240NoNo
17506773LAPAROSCOPIC FORCEPS ASSEMBLY WITH AN OPERABLE MECHANISMOctober 2021October 2024Allow3520NoNo
17476734ELECTROSURGICAL UNIT AND SYSTEMSeptember 2021March 2025Allow4220NoNo
17461498ABLATION APPLICATOR WITH A MATRIX FILLED WITH PARTICLESAugust 2021May 2024Allow3310NoNo
17404113TEMPERATURE-SENSING ELECTRICALLY-CONDUCTIVE PLATE FOR AN END EFFECTOR OF AN ELECTROSURGICAL INSTRUMENTAugust 2021August 2024Abandon3610NoNo
17371683THERMAL ACCELERANT COMPOSITIONS AND METHODS OF USEJuly 2021February 2024Allow3110NoNo
17370812APPARATUS AND METHODS FOR MINIMALLY INVASIVE DISSECTION AND MODIFICATION OF TISSUESJuly 2021March 2026Allow5650YesNo
17344211METHODS FOR CARRYING OUT A CARDIAC PROCEDUREJune 2021August 2025Abandon5020NoNo
17314211MULTIFUNCTIONAL MEDICAL DEVICEMay 2021August 2024Allow3920NoNo
17306402MULTIFUNCTIONAL MEDICAL DEVICEMay 2021August 2024Allow3920NoNo
17198088APPARATUS AND SYSTEMS FOR MINIMALLY INVASIVE DISSECTION OF TISSUESMarch 2021October 2023Allow3110YesNo
17189772METHODS AND SYSTEMS FOR TREATING DIABETES AND RELATED DISEASES AND DISORDERSMarch 2021August 2021Allow510NoNo
17189892FORCEPS WITH LINEAR TRIGGER MECHANISMMarch 2021January 2025Allow4630YesNo
17187527APPARATUS AND SYSTEMS FOR MINIMALLY INVASIVE DISSECTION OF TISSUESFebruary 2021March 2024Allow3720NoNo
17181969METHODS AND SYSTEMS FOR TREATING DIABETES AND RELATED DISEASES AND DISORDERSFebruary 2021March 2026Abandon6030NoNo
17159563LARGE VOLUME TISSUE REDUCTION AND REMOVAL SYSTEM AND METHODJanuary 2021February 2025Abandon4920NoNo
17148506OPTICAL-GUIDED ABLATION SYSTEM FOR USE WITH PULSED FIELDS OR OTHER ENERGY SOURCESJanuary 2021September 2021Allow810NoNo
17256551INTRAVASCULAR CATHETER TIP ELECTRODE ASSEMBLIESDecember 2020February 2026Allow6050YesNo
17129398ARTICULATING SURGICAL INSTRUMENT AND METHOD OF ASSEMBLING THE SAMEDecember 2020November 2025Abandon5850YesNo
17119895APPARATUS AND SYSTEMS FOR MINIMALLY INVASIVE DISSECTION OF TISSUESDecember 2020August 2023Allow3220NoNo
17119783TISSUE MAPPING AND TREATMENTDecember 2020February 2025Allow5011NoNo
17112515Instrument for Electrosurgical TreatmentDecember 2020March 2023Abandon2750NoNo
17106926FLUX DISAMBIGUATION FOR TELEOPERATED SURGICAL SYSTEMSNovember 2020December 2024Allow4920NoNo
17099870INTEGRATED LC FILTERS IN CATHETER DISTAL ENDNovember 2020November 2023Allow3600NoNo
17056198ELECTRO-THERMAL THERAPY FOR THE TREATMENT OF DISEASED OR UNWANTED TISSUENovember 2020July 2025Allow5640YesNo
17099272METHOD AND APPARATUS FOR RAPID AND SAFE PULMONARY VEIN CARDIAC ABLATIONNovember 2020January 2025Allow5030NoNo
17055236PLASMA APPLICATION APPARATUSNovember 2020April 2024Abandon4110NoNo
17093236STEAM POP DETECTIONNovember 2020April 2023Allow2900NoNo
17090886CATHETER WITH IMPROVED IRRIGATED TIP ELECTRODE HAVING TWO-PIECE CONSTRUCTION, AND METHOD OF MANUFACTURING THEREFORNovember 2020July 2023Allow3210NoNo
17090760CATHETER WITH TAPERED SUPPORT MEMBER FOR VARIABLE ARCUATE DISTAL ASSEMBLYNovember 2020November 2023Allow3610NoNo
17086811VESSEL-SEALING DEVICE INCLUDING FORCE-BALANCE INTERFACE AND ELECTROSURCIAL SYSTEM INCLUDING SAMENovember 2020March 2023Allow2800NoNo
17080234VESSEL SEALING DEVICEOctober 2020November 2023Allow3720NoNo
16948752ENDOSCOPIC CATHETER DEVICESeptember 2020January 2026Allow6020NoYes
17030989SURGICAL END EFFECTOR JAW AND ELECTRODE CONFIGURATIONSSeptember 2020October 2025Allow6050YesNo
17023367SURGICAL INSTRUMENT AND METHOD OF ASSEMBLING SURGICAL INSTRUMENTSeptember 2020November 2025Allow6050YesNo
17020051END EFFECTOR ASSEMBLIES FOR SURGICAL INSTRUMENTSSeptember 2020January 2024Abandon4120YesNo
17016477POST ABLATION TISSUE ANALYSIS TECHNIQUESeptember 2020July 2023Allow3410YesNo
16979664TESTING DEVICE FOR AN ELECTROSURGICAL GENERATORSeptember 2020January 2026Allow6040YesNo
17012434ELECTROSURGICAL INSTRUMENT WITH TEXTURED JAWSSeptember 2020October 2023Allow3820YesNo
17011927Compositions, Systems, Kits, and Methods for Neural AblationSeptember 2020January 2024Allow4120NoNo
16977387ELECTROSURGICAL NETWORKSeptember 2020April 2025Abandon5530NoNo
16976567METHOD AND APPARATUS FOR IMPROVEMENT OF MICROCIRCULATIONAugust 2020October 2025Allow6030NoNo
17002208SURGICAL DEVICE AND METHODSAugust 2020March 2025Allow5431YesNo
16987145CUTTING ELECTRODE, SURGICAL INSTRUMENT AND METHOD FOR MANUFACTURING THE CUTTING ELECTRODEAugust 2020March 2025Allow5630NoNo
16940419ABLATION PLANNING SYSTEMJuly 2020December 2024Abandon5230NoNo
16897472DIRECTIONAL BALLOON TRANSSEPTAL INSERTION DEVICE FOR MEDICAL PROCEDURES WITH IMPROVED TRANSSEPTAL PUNCTURE SYSTEM WITH PUNCTURE MEMBER BALLOON SEALJune 2020March 2023Allow3300NoNo
16887576CLAMP ARM JAW TO MINIMIZE TISSUE STICKING AND IMPROVE TISSUE CONTROLMay 2020February 2023Allow3210NoNo
16887493METHOD OF OPERATING A COMBINATION ULTRASONIC / BIPOLAR RF SURGICAL DEVICE WITH A COMBINATION ENERGY MODALITY END-EFFECTORMay 2020February 2025Allow5740YesNo
16872538INSERT GUIDE MEMBERS FOR SURGICAL INSTRUMENTS, AND RELATED DEVICES, SYSTEMS, AND METHODSMay 2020March 2024Allow4620YesNo
16865633DEVICES AND METHODS FOR NERVE MODULATIONMay 2020October 2021Allow1820NoNo
16850045TWO-PART SEAL PLATE FOR VESSEL SEALER AND METHOD OF MANUFACTURING SAMEApril 2020August 2023Abandon4020NoNo
16848927MEDICAL DEVICE, METHOD OF MANUFACTURING MEDICAL DEVICE, AND METHOD OF ADJUSTING MEDICAL DEVICEApril 2020December 2024Abandon5631NoNo
16837418BIPOLAR ELECTROSURGICAL INSTRUMENT WITH MOVABLE ELECTRODE AND RELATED SYSTEMS AND METHODSApril 2020September 2021Allow1810NoNo
16835417ENDOSCOPIC VESSEL HARVESTER WITH INTEGRATED SUCTION LINEMarch 2020August 2023Abandon4020NoNo
16833024MEDICAL DEVICES WITH A FLEXIBLE ELECTRODE ASSEMBLY COUPLED TO AN ABLATION TIPMarch 2020August 2022Abandon2920NoNo
16827677APPARATUS, SYSTEMS, AND METHODS FOR MINIMALLY INVASIVE DISSECTION OF TISSUESMarch 2020February 2021Allow1110NoNo
16824003DIRECTIONAL BALLOON TRANSSEPTAL INSERTION DEVICE FOR MEDICAL PROCEDURESMarch 2020September 2025Abandon6040NoNo
16823024SINGLE-USE SURGICAL INSTRUMENTMarch 2020March 2023Abandon3610NoNo
16797765RECONFIGURABLE INSTRUMENTFebruary 2020September 2022Allow3110NoNo
16640044SPHINCTEROTOME DEVICE AND METHODS AND USES THEREOFFebruary 2020September 2021Allow1820YesNo
16637371VESSEL SEALING AND DISSECTION WITH CONTROLLED GAPFebruary 2020March 2024Allow4930YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner OUYANG, BO.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
16
Examiner Affirmed
8
(50.0%)
Examiner Reversed
8
(50.0%)
Reversal Percentile
79.7%
Higher than average

What This Means

With a 50.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
59
Allowed After Appeal Filing
17
(28.8%)
Not Allowed After Appeal Filing
42
(71.2%)
Filing Benefit Percentile
43.2%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 28.8% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner OUYANG, BO - Prosecution Strategy Guide

Executive Summary

Examiner OUYANG, BO works in Art Unit 3794 and has examined 281 patent applications in our dataset. With an allowance rate of 68.3%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 50 months.

Allowance Patterns

Examiner OUYANG, BO's allowance rate of 68.3% places them in the 30% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by OUYANG, BO receive 3.43 office actions before reaching final disposition. This places the examiner in the 93% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by OUYANG, BO is 50 months. This places the examiner in the 6% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a -1.7% benefit to allowance rate for applications examined by OUYANG, BO. This interview benefit is in the 9% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 18.8% of applications are subsequently allowed. This success rate is in the 18% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 17.0% of cases where such amendments are filed. This entry rate is in the 19% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 137.9% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 88% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 71.4% of appeals filed. This is in the 60% percentile among all examiners. Of these withdrawals, 60.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 71.8% are granted (fully or in part). This grant rate is in the 78% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 48% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 50% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.